FMR LLC 13D and 13G filings for Vertex Pharmaceuticals Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 09:34 am Sale | 2024-12-31 | 13G | Vertex Pharmaceuticals Incorporated VRTX | FMR LLC | 9,220,827 3.600% | -3,760,459 (-28.97%) | Filing |
| 2024-02-09 10:05 am Sale | 2024-02-08 | 13G | Vertex Pharmaceuticals Incorporated VRTX | FMR LLC | 12,981,286 5.037% | -4,895,488 (-27.38%) | Filing |
| 2023-02-09 12:39 pm Purchase | 2023-02-09 | 13G | Vertex Pharmaceuticals Incorporated VRTX | FMR LLC | 17,876,774 6.964% | 8,643,205 (+93.61%) | Filing |
| 2022-02-09 10:01 am Sale | 2022-02-08 | 13G | Vertex Pharmaceuticals Incorporated VRTX | FMR LLC | 9,233,569 3.631% | -4,273,301 (-31.64%) | Filing |
| 2021-02-08 10:35 am Sale | 2021-02-05 | 13G | Vertex Pharmaceuticals Incorporated VRTX | FMR LLC | 13,506,870 5.194% | -10,776,092 (-44.38%) | Filing |